Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Morphometric, DNA and PCNA in thin malignant melanomas

V Björnhagen1, E Månsson-Brahme, J Lindholm

  • 1Department of Plastic and Reconstructive Surgery, Karolinska Institute and Hospital, Stockholm, Sweden.

Medical Oncology and Tumor Pharmacotherapy
|January 1, 1993
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Neurotherapy for children and adolescents with psychiatric disorders: a state-of-the-art umbrella review of selected clinical methodologies.

Neuroscience and biobehavioral reviews·2025
Same author

Calculating dissolved marine oxygen values based on an enhanced Benthic Foraminifera Oxygen Index.

Scientific reports·2022
Same author

Heavy metal content of Swedish municipal wastewater sludge - status and goals.

Water science and technology : a journal of the International Association on Water Pollution Research·2017
Same author

Adsorption of formic acid on rutile TiO2 (110) revisited: an infrared reflection-absorption spectroscopy and density functional theory study.

The Journal of chemical physics·2015
Same author

Trends in cutaneous malignant melanoma in Sweden 1997-2011: thinner tumours and improved survival among men.

The British journal of dermatology·2014
Same author

Prognostic factors in localized invasive primary cutaneous malignant melanoma: results of a large population-based study.

The British journal of dermatology·2014
Same journal

Treatment of ovarian cancer: the state of the art.

Medical oncology and tumor pharmacotherapy·1993
Same journal

Clinical evaluation of the CORDIS vascular access port systems: a multicenter study.

Medical oncology and tumor pharmacotherapy·1993
Same journal

Expression of an adhesion molecule and homing in B-cell chronic lymphocytic leukaemia: I. Application of the HEV-binding assay to a clinical series.

Medical oncology and tumor pharmacotherapy·1993
Same journal

Ultrastructural investigation of DNA in megakaryoblastic leukemia by using osmium-ammine-B: comparison with several types of leukemia.

Medical oncology and tumor pharmacotherapy·1993
Same journal

T-lymphocyte sub-populations in orbito-ocular granulocytic sarcoma (OOGS) and acute myelocytic leukemia (AML): a preliminary study.

Medical oncology and tumor pharmacotherapy·1993
Same journal

Low dose cyclophosphamide, alpha-interferon and continuous infusions of interleukin-2 in advanced renal cell carcinoma.

Medical oncology and tumor pharmacotherapy·1993
See all related articles

Thin melanomas that metastasize often show distinct nuclear features. Pleomorphic and densely packed nuclei in thin melanomas are linked to recurrence, aiding in predicting melanoma metastasis risk.

Area of Science:

  • Oncology
  • Dermatopathology
  • Cancer Research

Background:

  • Accurate prediction of melanoma metastasis is crucial for patient outcomes.
  • Thin melanomas (<0.8 mm) with Clark level II-III invasion present a diagnostic challenge for predicting metastatic potential.
  • Morphometric analysis of nuclear features offers a potential avenue for improving prognostic accuracy.

Purpose of the Study:

  • To investigate specific nuclear morphometric parameters associated with metastasis in thin melanomas.
  • To identify cellular features that differentiate metastasizing thin melanomas from non-metastasizing ones.
  • To evaluate the utility of nuclear shape, density, and DNA content in predicting melanoma recurrence.

Main Methods:

  • A case control study involving 72 thin melanomas (thickness ≤0.8 mm, Clark level II-III).

Related Experiment Videos

  • Twenty-four thin metastasizing melanomas (TMM) were matched with 48 thin non-metastasizing melanomas (TNM) based on primary tumor site, thickness, invasion level, regression, and follow-up duration.
  • Conditional logistic regression analysis was employed to compare morphometric parameters including nuclear area, shape, density, nucleolar area, DNA content, and proliferating cell nuclear antigen (PCNA) expression.

    • Main Results:

    • Significant differences were observed between TMM and TNM in nuclear correlation coefficient (p=0.005), standard deviation of nuclear shape NCI (p=0.017), and nuclear density (p=0.030).
    • These findings indicate that thin melanomas with pleomorphic and potentially densely packed nuclei are associated with a higher risk of recurrence.
    • No significant differences were found in nuclear or nucleolar area, mean nuclear shape NCI, nuclear DNA content, or PCNA expression between the groups.

    Conclusions:

    • Nuclear morphometry, specifically parameters related to nuclear shape variability and density, can help differentiate metastasizing from non-metastasizing thin melanomas.
    • These quantitative nuclear features may serve as valuable biomarkers for predicting recurrence risk in thin melanoma.
    • Further research into these morphometric markers could improve prognostic models for melanoma.